Regenerate Primary Medical Research | Miami, FL

Research site

About

Regenerate PMR is a leading clinic that specializes in conducting cutting-edge clinical trials. Our team of experienced researchers and medical professionals are dedicated to advancing the field of medical research and development. We offer comprehensive services, from study design to data analysis, to help our clients bring their innovative therapies to market. Contact us today to learn more about how we can support your next clinical trial.

Location

8485 SW 40th St Suite 306, Miami, Florida, United States of America

Website

https://regeneratepmr.com/

Site insights

Top conditions

Top treatments

LPX-TI641

Vixarelimab

Inclisiran

Polypill

sodium

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Gerardo Masferrer

Verified by this site

Active trials

4 of 4 total trials

A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

CKJX839D12302 is a pivotal Phase III study designed to test the hypothesis that treatment with inclisiran sodium 300 milligram (mg) subcutaneous (s.c...

Active, not recruiting

Primary Prevention of Atherosclerotic Cardiovascular Disease

Drug: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL

Drug: Placebo in 1.5ml

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)

The purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of vixarelimab compared with placebo in participants with mo...

Active, not recruiting

Ulcerative Colitis

Drug: Placebo

Drug: Vixarelimab

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

This is an estimation-focused Phase 2 study designed to explore and quantify treatment-related changes across multiple clinical outcomes in patients...

Active, not recruiting

Alzheimer Disease

Drug: MAR

Safety and Pharmacokinetics of LPX-TI641 in Rheumatoid Arthritis and Psoriatic Arthritis

The goal of this clinical trial is to study the drug LPX-TI641 in patients with rheumatoid arthritis and psoriatic arthritis. We will compare the saf...

Enrolling

Rheumatoid Arthritis (RA)

Psoriatic Arthritis (PsA)

Drug: Placebo

Drug: LPX-TI641

Trial sponsors

L

N

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms